Starna Therapeutics
Clinical trials sponsored by Starna Therapeutics, explained in plain language.
-
New hope for leukemia patients who have run out of options
Disease control Not yet recruitingThis early-stage study tests an experimental drug called STR-P004 in 11 adults with relapsed or treatment-resistant CD19-positive acute lymphoblastic leukemia. The main goals are to check safety and find the right dose, while also looking for signs that the drug can fight the can…
Phase: NA • Sponsor: Starna Therapeutics • Aim: Disease control
Last updated May 17, 2026 02:45 UTC
-
New drug aims to calm immune attacks on kidneys
Disease control Not yet recruitingThis early study tests a new drug called STR-P004 in 9 adults with immune-mediated kidney diseases. The goal is to see if the drug is safe and how the body processes it. Participants will receive up to 8 infusions over 1-2 months, with possible dose increases to find the best lev…
Phase: NA • Sponsor: Starna Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:05 UTC